Answers are grounded in this paper and cite their sources.
Atopic dermatitis (AD) is a chronic, relapsing, and remitting inflammatory skin disease whose onset typically occurs early in life. AD pathophysiology includes genetic, immune, and environmental factors contributing to chronic inflammation. A rapidly evolving understanding of the pathogenesis of AD has led to the development of several treatment options for AD in adults, including topicals, phototherapy, and systemic therapies. Here, we provide a concise summary of AD pathophysiology with a focus on implications for systemic therapy.
No takes yet. Share an insight, caveat, or question.
Kirchhof et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: